ghk cu molecule GHK-CU Copper Peptide 50MG - LC-MS Tested Molecular structure of the tripeptide

The broad spectrum of its therapeutic applications highlights the need for continued research and clinical trials to fully understand and harness its potential

Two separate human clinical trials have investigated this compound: Ulcerative Colitis Trial Clinical investigation of this compound in patients with ulcerative colitis examined the compounds GI-protective properties properties that are consistent with its gastric origin and documented activity on intestinal permeability barriers in animal models

The Vitamin B12 Shot retains more of the vitamin versus supplements which lose up to 88 percent of the vitamin

evaluating at week 2 of a loading phase is premature

Research has not established GHK-Cu safety during pregnancy or breastfeeding

Whether its inclusion provides meaningful advantage over formulations containing only tirzepatide and B12 remains uncertain